Organic Process Research & Development
Communication
Operational Conditions for the Photochemical Flow
Reactor. Considering two syringes and the reactor volume (1
mL), the injection flow rate was 50 μL/min for a residence
time of 10 min. For reactor equilibration, both solutions were
infused for 3 times the desired residence time, and the reaction
effluent was discharged. After the reactor equilibration, the
reaction effluent was collected in a single flask. The isolated
yield was measured after continuous production of the desired
oxindole for 1.5 h. For example, the reaction effluent (7 mL)
was collected in a single flask, and this crude material was
purified by flash column chromatography as described below.
Each reaction was monitored, and every 10 min one sample
of the reaction effluent was collected for analysis by TLC and
GC/MS. This protocol was repeated three times. For sample
extraction, a saturated aqueous solution of sodium bicarbonate
(0.5 mL) and CHCl3 (2 mL) were added to the flask. The
resulting mixture was stirred, and the organic layer was
removed. In the same flask, the aqueous layer was washed with
CHCl3 (2 mL). The combined organic layers were dried over
MgSO4, filtered, and analyzed by TLC and GC/MS.
9 Hz, J = 2 Hz), 7.39 (d, 1H, J = 2 Hz) ppm; 13C NMR
(DMSO-d6, 75 MHz) δ 24.1, 26.2, 41.9, 45.3, 109.3, 122.7,
125.6, 127.1, 135.9, 142.6, 170.5, 179.3 ppm; IR (KBr) νmax
3370, 3191, 2965, 1702, 1681, 1612, 1495, 1081, 1054 cm−1;
MS (EI+) m/z (relative intensity) 252 (M+, 42), 194 (100).
2-(7-Phenyl-1,3-dimethyl-2-oxoindolin-3-yl)acetamide
(3e).14 Yield = 60%, 0.026 g (from 4.3 mL of output solution,
1
0.02 M); Rf = 0.39 (9:1 CHCl3/MeOH); H NMR (CDCl3,
500 MHz) δ 1.50 (s, 3H), 2.74 (d, 1H, J = 15 Hz), 2.76 (s,
3H), 2.87 (d, 1H, J = 15 Hz), 5.32 (br s, 1H), 6.53 (br s, 1H),
7.08−7.12 (m, 2H), 7.34−7.41 (m, 6H) ppm; 13C NMR
(CDCl3, 125 MHz) δ 24.0, 30.6, 43.9, 45.4, 121.8, 122.4,
125.9, 127.8, 128.8, 130.0, 131.4, 134.4, 138.9, 139.8, 171.5,
181.8 ppm; IR (ATR) νmax 3339, 3201, 2963, 1699, 1679,
1613, 1458 cm−1; MS (EI+) m/z (relative intensity) 294 (M+,
46), 236 (100).
2-(3-Benzyl-1-methyl-2-oxoindolin-3-yl)acetamide (3f).
Yield = 82%, 0.169 g (from 7 mL of output solution, 0.068
1
M); Rf = 0.31 (9:1 CHCl3/MeOH); H NMR (CDCl3, 500
MHz) δ 2.79 (d, 1H, J = 15 Hz), 2.96 (s, 3H), 2.98 (d, 1H, J =
15 Hz), 3.09 (d, 1H, J = 15 Hz), 3.15 (d, 1H, J = 15 Hz), 5.36
(br s, 1H), 6.30 (br s, 1H), 6.58 (d, 1H, J = 10 Hz), 6.78 (d,
2H, J = 10 Hz), 7.02−7.09 (m, 4H), 7.18 (dd, 1H, J = 10 Hz, J
= 1 Hz), 7.21 (d, 1H, J = 5 Hz) ppm; 13C NMR (CDCl3, 125
MHz) δ 26.1, 42.3, 43.7, 52.1, 108.2, 122.6, 123.8, 126.9,
127.6, 128.5, 130.0, 130.3, 135.0, 143.6, 171.3, 179.2 ppm; IR
(ATR) νmax 3391, 3198, 2936, 1714, 1682, 1670, 1613, 1495
cm−1; MS (EI+) m/z (relative intensity) 294 (M+, 46), 160
(100).
Typical Procedure for Purification of Oxindoles 3a−j.
The reaction effluent (7 mL) was used without quenching to
load a glass chromatography column (silica gel; diameter = 4
cm, length = 20 cm). This glass column was very efficient for
separation of the oxindole and formamide. A 9:1 CHCl3/
MeOH mixture was used as the eluent.
To recycle formamide, prior to chromatography a simple
vacuum distillation was used.
2-(1,3-Dimethyl-2-oxoindolin-3-yl)acetamide (3a).14 Yield
1
2-(3-Allyl-1-methyl-2-oxoindolin-3-yl)acetamide (3g).19
= 99%, 0.303 g; Rf = 0.39 (9:1 CHCl3/MeOH); H NMR
1
Yield = 77%, 0.263 g; Rf = 0.35 (9:1 CHCl3/MeOH); H
(CDCl3, 500 MHz) δ 1.45 (s, 3H), 2.68 (d, 1H, J = 15 Hz),
2.82 (d, 1H, J = 15 Hz), 3.24 (s, 3H), 5.35 (br s, 1H), 6.42 (br
s, 1H), 6.86 (d, 1H, J = 5 Hz), 7.07−7.10 (m, 1H), 7.27−7.30
(m, 2H) ppm; 13C NMR (CDCl3, 125 MHz) δ 23.7, 26.5,
43.4, 46.1, 108.5, 122.8, 123.0, 128.3, 133.4, 142.9, 171.6,
180.7 ppm; IR (ATR) νmax 3383, 3202, 2967, 1713, 1699,
1680, 1614, 1495 cm−1; MS (EI+) m/z (relative intensity) 218
(M+, 40), 160 (100).
NMR (CDCl3, 500 MHz) δ 2.55−2.64 (m, 2H), 2.72 (d, 1H, J
= 15 Hz), 2.86 (d, 1H, J = 15 Hz), 3.23 (s, 3H), 4.95−5.03 (m,
2H), 5.17 (br s, 1H), 5.38−5.46 (m, 1H), 6.26 (br s, 1H), 6.85
(d, 1H, J = 10 Hz), 7.08 (td, 1H, J = 8 Hz, J = 1 Hz), 7.25−
7.27 (m, 1H), 7.29 (td, 1H, J = 8 Hz, J = 1.5 Hz) ppm; 13C
NMR (CDCl3, 125 MHz) δ 26.4, 41.7, 42.3, 50.3, 108.4, 119.7,
122.8, 123.4, 128.5, 131.0, 131.6, 143.6, 171.3, 179.5 ppm; IR
(ATR) νmax 3405, 3203, 2963, 1717, 1681, 1667, 1631, 1613,
1495 cm−1; MS (EI+) m/z (relative intensity) 244 (M+, 40),
160 (100).
2-(5-Methyl-1,3-dimethyl-2-oxoindolin-3-yl)acetamide
(3b).14 Yield = 47%, 0.110 g (from 5 mL of output solution);
Rf = 0.39 (9:1 CHCl3/MeOH); 1H NMR (CDCl3, 500 MHz)
δ 1.45 (s, 3H), 2.34 (s, 3H), 2.68 (d, 1H, J = 15 Hz), 2.80 (d,
1H, J = 15 Hz), 3.22 (s, 3H), 5.21 (br s, 1H), 6.55 (br s, 1H),
6.75 (d, 1H, J = 10 Hz), 7.07−7.09 (m, 2H) ppm; 13C NMR
(CDCl3, 125 MHz) δ 21.3, 23.6, 26.6, 43.6, 46.1, 108.3, 123.7,
128.7, 132.7, 133.4, 140.5, 171.6, 180.7 ppm; IR (ATR) νmax
3381, 3189, 2963, 1707, 1695, 1683, 1606, 1502 cm−1; MS
(EI+) m/z (relative intensity) 232 (M+, 38), 174 (100).
2-(5-Methoxy-1,3-dimethyl-2-oxoindolin-3-yl)acetamide
(3c).14 Yield = 74%, 0.258 g; Rf = 0.28 (9:1 CHCl3/MeOH);
1H NMR (CDCl3, 500 MHz) δ 1.45 (s, 3H), 2.68 (d, 1H, J =
15 Hz), 2.79 (d, 1H, J = 15 Hz), 3.22 (s, 3H), 3.79 (s, 3H),
5.30 (br s, 1H), 6.58 (br s, 1H), 6.76 (d, 1H, J = 10 Hz), 6.81
(dd, 1H, J = 10 Hz, J = 2.5 Hz), 6.90 (d, 1H, J = 2.5 Hz) ppm;
13C NMR (CDCl3, 125 MHz) δ 23.5, 26.6, 43.6, 46.4, 55.9,
108.8, 110.5, 112.6, 134.8, 136.3, 156.5, 171.5, 180.4 ppm; MS
(EI+) m/z (relative intensity) 248 (M+, 82), 190 (100).
2-(5-Chloro-1,3-dimethyl-2-oxoindolin-3-yl)acetamide
(3d).14 Yield = 86%, 0.306 g; Rf = 0.49 (9:1 CHCl3/MeOH);
1H NMR (DMSO-d6, 300 MHz) δ 1.20 (s, 3H), 2.61 (d, 1H, J
= 15 Hz), 2.80 (d, 1H, J = 15 Hz), 3.09 (s, 3H), 6.59 (br s,
1H), 6.97 (d, 1H, J = 9 Hz), 7.22 (br s, 1H), 7.26 (dd, 1H, J =
2-(3-Allyl-1-benzyl-2-oxoindolin-3-yl)acetamide (3h).
Yield = 97%, 0.218 g (from 7 mL of output solution, 0.1
1
M); Rf = 0.38 (9:1 CHCl3/MeOH); H NMR (CDCl3, 500
MHz) δ 2.60−2.69 (m, 2H), 2.77 (d, 1H, J = 15 Hz), 2.92 (d,
1H, J = 15 Hz), 4.86 (d, 1H, J = 15 Hz), 4.96−5.07 (m, 3H),
5.13 (br s, 1H), 5.39−5.47 (m, 1H), 6.14 (br s, 1H), 6.72 (d,
1H, J = 8 Hz), 7.05 (td, 1H, J = 8 Hz, J = 1 Hz), 7.17 (td, 1H, J
= 8 Hz, J = 1 Hz), 7.23−7.33 (m, 6H) ppm; 13C NMR
(CDCl3, 125 MHz) δ 42.0, 42.4, 44.1, 50.3, 109.4, 119.9,
122.8, 123.4, 127.4, 127.7, 128.4, 128.8, 130.9, 131.6, 135.9,
142.8, 171.2, 179.6 ppm; MS (EI+) m/z (relative intensity)
320 (M+, 10), 91 (100); HRMS (ESI-TOF) calcd for
C20H21N2O2 [M + H]+ 321.1603, found (M + 1) 321.1601.
2-(1-Benzyl-3-methyl-2-oxoindolin-3-yl)acetamide (3i).
Yield = 90%, 0.127 g (from 5 mL of output solution, 0.068
1
M); Rf = 0.39 (9:1 CHCl3/MeOH); H NMR (CDCl3, 500
MHz) δ 1.49 (s, 3H), 2.75 (d, 1H, J = 15 Hz), 2.89 (d, 1H, J =
15 Hz), 4.94 (s, 2H), 5.36 (br s, 1H), 6.28 (br s, 1H), 6.73 (d,
1H, J = 8 Hz), 7.04 (td, 1H, J = 8 Hz, J = 1 Hz), 7.16 (td, 1H, J
= 8 Hz, J = 1.5 Hz), 7.24−7.28 (m, 2H), 7.30−7.34 (m, 4H)
ppm; 13C NMR (CDCl3, 125 MHz) δ 24.2, 43.4, 44.0, 46.2,
109.6, 122.9, 123.1, 127.3, 127.8, 128.3, 128.9, 133.3, 135.9,
F
Org. Process Res. Dev. XXXX, XXX, XXX−XXX